Expression of lymphocyte activation markers of preterm neonates is associated with perinatal complications by Sava, Florentina et al.
RESEARCH ARTICLE Open Access
Expression of lymphocyte activation
markers of preterm neonates is associated
with perinatal complications
Florentina Sava1, Gergely Toldi1* , András Treszl2, Júlia Hajdú1, Ágnes Harmath1, Tivadar Tulassay2,3
and Barna Vásárhelyi3,4
Abstract
Background: Inappropriate activation of T lymphocytes plays an important role in perinatal complications. However,
data on T lymphocyte activation markers of preterm infants is scarce. We investigated the association between gender,
gestational and postnatal age, preeclampsia (PE), premature rupture of membranes (PROM) as well as prenatal steroid
treatment (PS) and the frequency of activated T lymphocyte subsets (HLA-DR+, CD69+, CD25+, CD62L+) and
major T lymphocyte subpopulations (CD4, CD8, Th1, Th2, naïve, memory) in peripheral blood during the first
postnatal week in preterm infants.
Results: Cord blood and peripheral blood samples were collected from 43 preterm infants on the 1st, 3rd,
and 7th days of life. We assessed the frequency of the above T lymphocyte subsets using flow cytometry. The ‘mixed
effect model’ was used to analyze the effects of clinical parameters on T lymphocyte markers. The frequency
of CD25+ T lymphocytes was higher in PROM. The frequency of CD4+ and CD8+ cells and the CD4+/CD8+
cell ratio was decreased in PE. The frequency of CD62L+ T lymphocytes was higher in male compared with
female infants. PS did not affect the frequency of the investigated markers. CD4+ CD25+ cells had a lower
frequency at birth than on day 7. Th2 lymphocytes had a lower frequency on postnatal days 1 and 3 when
compared to day 7.
Conclusions: Our observations indicate that alterations affecting the expression of T lymphocyte activation
markers are associated with the above factors and may play a role in the development of perinatal complications.
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Background
T lymphocyte activation is a finely regulated, complex,
cascade of events that result in the expression of cyto-
kine receptors, production and secretion of cytokines,
upregulation of cell surface molecules, and activation of
direct cell killing. Therefore, it is one of the cornerstones
of the implementation of an appropriate immune response
for different types of antigens [1].
Preterm birth (birth before the 37th week of gestation)
affects an estimated number of 15 million infants each
year globally [2]. The rate of preterm birth ranges from
5 to 18 % percent. Premature babies face numerous
acute and chronic complications, including respiratory,
cardiovascular, gastrointestinal, and perhaps most im-
portantly, neurodevelopmental problems. Risk factors
associated with preterm labor include previous preterm
births or miscarriages, multiple pregnancy, in vitro
fertilization, cervical or placental insufficiency, smoking,
poor nutrition, hypertensive disorders, infections, stress
and trauma. Numerous studies to date have shown that
preterm deliveries associated with preeclampsia (PE),
premature rupture of membranes (PROM), intrauterine
infection and respiratory distress syndrome (RDS) are
linked with higher levels of neonatal adaptive immune
response [3]. However, data on T lymphocyte activation
markers of preterm infants is scarce [4].
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The most important activation molecules expressed on
T lymphocytes can be classified as early activation markers,
such as CD69 and CD25, and late activation markers, such
as CD62L and HLA-DR. Additionally, very late activation
markers, such as VLA-1 have also been described, playing
a role in lymphocyte adhesion and extravasation [5].
CD69 is regarded as the earliest cell surface activation
marker of both umbilical cord and peripheral blood
mononuclear cells. Activated neutrophils and eosino-
phils can also express CD69, therefore it is not restricted
to activated lymphocytes. Bone marrow myeloid precur-
sors, platelets and epidermal Langerhans cells also ex-
press CD69 constitutively. The engagement of CD69 can
activate NK and T cells, resulting in increased cytotoxic
activity and pro-inflammatory cytokine production [6].
CD69 seems to be expressed in higher levels on the sur-
face of activated neonatal cells when compared to adults
[7]. Upregulation of CD69 on NK cells was identified as
a sensitive marker of neonatal infection [8].
CD25, or the alpha subunit of the IL-2 receptor, is in-
volved in the early stage of lymphocyte activation, but it
also seems to be critical in maintaining self tolerance
and immune homeostasis. Early work on CD4+ CD25
high + cells later termed as regulatory T cells showed
that their activation via their T cell receptor (TCR)
generates non-specific suppressor cells that suppress
the activation of any CD4+ or CD8+ T cell [9]. FoxP3+
regulatory T cells, also characterized by high expression of
CD25 are present at the fetal-maternal interface and are
important for the maternal acceptance of the allogeneic
fetus [10].
CD62L (L-selectin) is considered a late activation
marker and a key regulator of T cell trafficking. It acts as
a homing receptor for lymphocytes to enter secondary
lymphoid tissues via high endothelial venules (HEV).
Following activation, CD62L is rapidly downregulated
on T cells, which prevents effector T cells from traffick-
ing to lymph nodes through HEV [11]. CD62L is acti-
vated during the first postnatal days in preterm infants
with RDS, and this activation is associated with the de-
velopment of bronchopulmonary dysplasia (BPD) [12].
Furthermore, it was also demonstrated that carriers of
the L-selectin 213Ser allele are at increased risk for pre-
mature birth and BPD [13].
HLA-DR molecules are important in antigen process-
ing and presentation, mediating antigen-specific T cell
activation [14]. It is known that low levels of HLA-DR
expression on monocytes contributes to impaired neo-
natal host defense, especially in preterm infants [15]. De-
creased expression of HLA-DR molecules in preterm
newborns is linked with development of several compli-
cations, such as high incidence of bacterial infections
and pulmonary morbidity, especially in the presence of
RDS [16, 17].
The aim of this study was to assess the association of
gender, gestational and postnatal age, preeclampsia (PE),
premature rupture of membranes (PROM) and prenatal
steroid treatment (PS) with the frequency of activated
T lymphocyte subsets (CD69+, CD25+, CD62L+, HLA-
DR) and major T lymphocyte subpopulations (CD4, CD8,
Th1, Th2, naïve, memory) in peripheral blood during
the first postnatal week in preterm neonates. Since data
on the physiological frequency of these cell subsets is
challenging to obtain, we aimed to gather preliminary
data to describe the dynamic postnatal alteration of
these parameters in preterm neonates affected by dif-
ferent perinatal factors.
Methods
Patients
We enrolled 43 preterm infants (22 female and 21 male)
in this study. Gestational age was 30 (25–33) weeks,
while birthweight was 1300 (490–1980) g at birth. The
suspected ground for preterm birth was PE in 8 cases,
PROM in 13 cases, and could not be settled in 22 cases.
PS treatment was applied in 25 cases. All infants had a
highly suspected or proven intrauterine infection based
on standard criteria [18, 19]. PROM cases were coupled
with elevated IL-6 levels (256.2 (64.8–2358.9) pg/ml)
measured in cord blood, while IL-6 levels in cord
blood of infants who had no PROM were normal
(11.6 (2.9–45.1) pg/ml). Patient characteristics are
summarized in Table 1.
Written informed consent was obtained from parents
of subjects, and our study was reviewed and approved
by an independent ethical committee of the institution
(Semmelweis University, Budapest). The study was ad-
hered to the tenets of the most recent revision of the
Declaration of Helsinki.
Table 1 Clinical characteristics of preterm neonates enrolled in
the study
Gestational age (weeks) 30 (25–33)
No. of infants born before 29th week 13 (30 %)
No. of infants born on 29-30th week 15 (35 %)
No. of infants born after 30th week 15 (35 %)
Birth weight (grams) 1300 (490–1980)
Apgar score at 1 min 8 (5–9)
Apgar score at 5 min 9 (7–10)
No. of male infants 21 (49 %)
No. of neonates born by Cesarean section 26 (60 %)
No. of neonates with maternal steroid prophylaxis 25 (58 %)
No. of neonates with suspected intrauterine infection 43 (100 %)
No. of preeclampsia 8 (19 %)
No. of premature rupture of membranes 13 (30 %)
Data are presented as median (range)
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Sample collection
Cord blood mononuclear cells (CBMCs) were separated
by a standard density gradient centrifugation (Ficoll Paque,
Amersham Biosciences AB, Uppsala, Sweden, 25 min,
400 g, 22 °C) from freshly drawn blood collected in lithium
heparin-treated tubes (BD Vacutainer, BD Biosciences, San
Jose, CA, USA). Peripheral blood samples were taken on
the 1st, 3rd, and 7th postnatal days of life.
Flow cytometry
CBMCs and peripheral whole blood were stained for
30 min at room temperature in the dark with the
following monoclonal antibodies: PE Cy7-conjugated
CD4, APC-Cy7-conjugated CD8, FITC-conjugated CD25,
PerCP-conjugated CD62L, APC-conjugated CXCR3,
PE-conjugated CCR4, APC-conjugated CD69, PerCP-
conjugated HLA-DR, FITC-conjugated CD45RA, PE-
conjugated CD45RO in separate tubes, respectively
(all from BD Biosciences). After lysing red blood cells and
washing, CBMCs and PBMCs were analyzed on a BD
FACSAria flow cytometer (BD Biosciences) equipped with
488 nm and 633 nm excitation lasers. Data were processed
using the FACSDiVa software. Figure 1 demonstrates the
gating strategy applied.
Fig. 1 Gating strategy of flow cytometry measurements. Example of a representative sample. FSC – forward scatter, SSC – side scatter
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Th1 cells were defined as CD4+ CXCR3+, while Th2
cells were defined as CD4+ CCR4+. Naïve T cells were
defined as CD4+ CD45RA+, while memory T cells were
defined as CD4+ CD45RO+.
Statistics
Data are expressed as median (range). The independent
effects of gestational and postnatal age, PE, PROM, PS
and gender were analyzed using the ‘mixed effect model’
method. This is a statistical model containing both fixed
effects and random effects. It is particularly used in set-
tings where repeated measurements are made on the
same statistical units (ie. longitudinal studies), or where
measurements are made on clusters of related statistical
units [20]. Statistics were calculated at 5 % significance
level (p = 0.05) using the SAS software (Cary, NC, USA).
A nominal p value < 0.05 was considered statistically sig-
nificant. No adjustment for multiplicity was performed,
thus some of p values may be spurious.
Results
Results are summarized in Table 2 and Fig. 2.
The frequency of CD4+ CD25+ and CD8+ CD25+ ac-
tivated T lymphocytes was higher in cases with PROM
at all time points. We observed a decrease in the fre-
quency of CD4+ and CD8+ T lymphocytes as well as the
CD4+/CD8+ T cell ratio in PE compared to infants not
affected by PE at all time points. The frequency of CD4+
CD62L+ and CD8+ CD62L+ T lymphocytes was higher
in male infants when compared to female infants at all
time points.
None of the investigated factors had an effect on the
expression of the HLA-DR and CD69 activation markers,
or the frequency of Th1 (CD4+ CXCR3+), Th2 (CD4+
CCR4+), naïve (CD45RA+) and memory (CD45RO+)
T cell subsets.
The frequency of Th1 (CD4+ CXCR3+) lymphocytes
was higher in infants born before the 29th gestational
week compared to those born on the 29-30th gestational
week on postnatal days 1 and 3.
When we looked at the effect of postnatal age (day 1,
3 and 7 of life) on the frequency of the investigated
markers and subsets, we detected several changes. CD4+
T cells have a higher frequency on postnatal days 0 and
3 when compared to day 7. CD4+ CD25+ cells had a
lower frequency on postnatal day 0 than on day 7. Of
note, Th2 (CD4+ CCR4+) lymphocytes also had a lower
frequency on postnatal days 1 and 3 when compared
to day 7.
Discussion
Both prenatal and postnatal inflammation are important
factors in the pathogenesis of many adverse outcomes in
preterm infants. An important feature of the inflamma-
tory response is T lymphocyte activation and the expres-
sion of early and late activation markers on T cells.
Luciano et al. demonstrated that preterm deliveries are
associated with higher levels of T cell activation markers,
such as CD25, HLA-DR, and CD69 compared to term
deliveries. In their study, clinical chorioamnionitis was
also associated with an increase in T cell activation
markers. Their findings support that fetal adaptive
immune activation in utero is closely associated with
preterm labor [4].
Our study shows that the frequency of CD4+ CD25+
and CD8+ CD25+ activated T lymphocytes is higher in
cases with PROM. Similarly to other obstetrical patholo-
gies, the etiology of PROM is multifactorial. However,
there is evidence suggesting that subclinical intrauterine
infection is a major factor in the pathogenesis of PROM
[21]. The pathogens ascending into the decidua and en-
tering the fetal membranes generate a cascade of mater-
nal and fetal inflammatory responses that finally result
in membrane weakening and rupture [22]. In our patient
population, PROM was also associated with an elevation
of cord blood IL-6 levels, indicating ongoing inflamma-
tion probably due to intrauterine infection in these
infants. The increased expression of CD25 on neonatal
T lymphocytes might be another representation of this
inflammatory response.
PE is a major cause of fetal and maternal morbidity
and mortality and is recognized as a multisystem dis-
order of human pregnancy. Although maternal immuno-
logical alterations, such as an increase in the Th17/Treg
ratio [23], are relatively well described in PE, very
limited information is available on how this disorder
affects the fetal/neonatal immune system. In our
Table 2 Significant results of mixed effect model analysis for
the investigated factors. “% change” is expressed vs. Day 7 for
postnatal age, vs. PE (present) for preeclampsia, vs. PROM (present)
for premature rupture of membranes, vs. Boys for gender, vs.
< 29 weeks for gestational age
T cell subset Effect p Estimate % change
CD4+ Day 0 0.0487 0.04143 4
Day 3 0.0018 0.06641 6
No PE 0.023 0.09089 9
CD8+ No PE 0.0371 0.02683 2
CD4+ CD25+ Day 0 0.0331 −0.1305 −87
No PROM 0.0219 −0.1826 −83
CD8+ CD25+ No PROM 0.0285 −0.1592 −86
CD4+ CD62L+ Boys 0.0572 0.1071 10
CD8+ CD62L+ Boys 0.0309 0.1404 15
CD4+ CXCR3+ 29-30 weeks 0.0291 −0.1256 −88
CD4+ CCR4+ Day 1 0.0341 −0.1342 −87
Day 3 0.024 −0.1431 −86
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current study, we observed a decrease in the frequency
of CD4+ and CD8+ T lymphocytes as well as the
CD4+/CD8+ T cell ratio in PE compared to infants
not affected by PE. These findings are in line with
previous results [3]. However, no clear cause of this
phenomenon has been identified. Theoretically, intrauter-
ine malnutrition that often affects fetuses in PE pregnan-
cies, may be a factor delaying or inhibiting maturation if
immune cell types.
The frequency of CD62L+ or L-selectin expressing T
lymphocytes was higher in male infants when compared
to female neonates in our study. Previous investigations
demonstrated that the altered expression and polymor-
phisms of selectins are related to prematurity and BPD
[13]. Male vulnerability has been previously noted in
infants. Males had more postnatal complications com-
pared to females, including lower Apgar scores, higher
supplemental oxygen need, higher rates of RDS, a poor
Fig. 2 Box-plots representing frequency values of the investigated cell subsets in different subgroups of preterm infants at birth (Day 0) and on days 1,
3 and 7 of life. Horizontal line: median, box: interquartile range, whisker: range. PE – preeclampsia, PROM – premature rupture of membranes.
*p < 0.05 vs. No PROM, **p < 0.05 vs. Male infants, ***p < 0.05 vs. No PE, #p < 0.05 vs. Day 0, ##p < 0.05 vs. Day 0
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neurological outcome at follow-up, and a higher overall
perinatal mortality [24]. It has also been suggested that
lung immaturity in premature boys contributes to their
poorer outcome [25]. Thus our results might indicate
that the elevated morbidity of male infants is closely
linked to a higher frequency of CD62L+ lymphocytes.
This is also in line with findings of Turunen et al. who
demonstrated that RDS is associated with a lower T cell
count and a higher frequency of CD62L expressing cells.
The authors concluded that increased frequency of
activated T cells predicts the development of BPD, and
systemic T cell activation could mediate inflammation
contributing to its pathogenesis [12].
Prenatal steroids undisputedly decrease neonatal mor-
bidity and mortality by improving fetal lung maturation.
The thymus is essential for the development and selec-
tion of T cells, and thymocytes are very sensitive to
steroids [26]. In the current study, PS treatment did not
affect the frequency of lymphocyte activation markers
during the first postnatal week of life. Thus, based on
our results, PS does not exert an immunomodulatory
effect on the frequency of activated lymphocytes investi-
gated in this study.
Maturation of the adaptive immune responses occurs
mostly after birth. Activated CD25+ CD4+ T cells had a
lower frequency at birth when compared to day 7 of life,
probably due to the lack of antigenic stimulation from
the environment in utero. Further studies are needed to
elucidate the effects of the transition occurring after birth.
Th2 lymphocytes appeared to have a lower frequency
on postnatal days 1 and 3 when compared to day 7.
Cytokine responses are skewed towards the Th2 direc-
tion in the fetus. This bias is thought to contribute to
the prevention of fetal rejection by the maternal immune
system [27]. Preterm and term neonates are thought to
be vulnerable to infection due to this bias to a Th2
phenotype [28]. However, parturition, independently of
the presence of infection, is associated with a marked
Th1 response. This might be represented by lower Th2
cell numbers directly after birth in preterm infants on
days 1 and 3 of life.
Conclusions
In conclusion, the frequency of CD25+ activated T
lymphocytes was higher in cases with PROM. The
frequency of CD4+ and CD8+ T lymphocytes as well
as the CD4+/CD8+ T cell ratio was lower in infants
affected by PE. The frequency of CD62L+ T lymphocytes
was higher in male infants.
Our observations indicate that alterations affecting the
expression of early and late T lymphocyte activation
markers in preterm infants are associated with the pres-
ence of PROM, PE, and gender, and may play a role in
the development of perinatal complications.
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